Human Complement Receptor 2 Gene B Regulates the Expression of the κ NF-Tsokos

[1]  V. Holers,et al.  Functional Analysis of the Human Complement Receptor 2 (CR2/CD21) Promoter: Characterization of Basal Transcriptional Mechanisms1 , 2002, The Journal of Immunology.

[2]  G. Tsokos,et al.  Protein kinase A enhances, whereas glycogen synthase kinase-3 beta inhibits, the activity of the exon 2-encoded transactivator domain of heterogeneous nuclear ribonucleoprotein D in a hierarchical fashion. , 2002, The Biochemical journal.

[3]  V. Holers,et al.  CR2/CD21 Proximal Promoter Activity Is Critically Dependent on a Cell Type-Specific Repressor1 , 2001, The Journal of Immunology.

[4]  T. Johnson,et al.  Improvement of the chromatin immunoprecipitation (ChIP) assay by DNA fragment size fractionation. , 2001, BioTechniques.

[5]  G. Tsokos,et al.  Multiple Transcription Factors Regulate the Inducible Expression of the Human Complement Receptor 2 Promoter1 , 2001, The Journal of Immunology.

[6]  W. Reith,et al.  Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter. , 2000, Journal of molecular biology.

[7]  G. Tsokos,et al.  Heterogeneous nuclear ribonucleoprotein D0 contains transactivator and DNA-binding domains. , 2000, The Biochemical journal.

[8]  C. Murre,et al.  Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms , 2000, Molecular and Cellular Biology.

[9]  E. Seto,et al.  Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.

[10]  G. Tsokos,et al.  Heterogeneous nuclear ribonucleoprotein D0B is a sequence-specific DNA-binding protein. , 1999, The Biochemical journal.

[11]  M. Dehoff,et al.  An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. , 1998, Journal of immunology.

[12]  J. Lambris,et al.  Transcriptional regulation of the complement receptor 2 gene: role of a heterogeneous nuclear ribonucleoprotein. , 1997, Journal of immunology.

[13]  N. Cooper,et al.  Epstein-Barr  Virus Binding to CD21 Activates the Initial Viral Promoter via NF-κB Induction , 1997, The Journal of experimental medicine.

[14]  V. M. Holers,et al.  Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. , 1997, Journal of immunology.

[15]  J. Weis,et al.  Expression of the murine CD21 gene is regulated by promoter and intronic sequences. , 1997, Journal of immunology.

[16]  R. Paro,et al.  Analysis of chromatin structure by in vivo formaldehyde cross-linking. , 1997, Methods.

[17]  Christopher C. Goodnow,et al.  C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity , 1996, Science.

[18]  J. Hiscott,et al.  Differential Transcriptional Activation in Vitro by NF-B/Rel Proteins (*) , 1995, The Journal of Biological Chemistry.

[19]  J. Hiscott,et al.  Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors , 1994, Journal of virology.

[20]  J. Daley,et al.  Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development , 1994, Molecular and cellular biology.

[21]  G. Nolan,et al.  The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.

[22]  J. Bonnefoy,et al.  CD21 is a ligand for CD23 and regulates IgE production , 1992, Nature.

[23]  A. Griffioen,et al.  Role of CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide. , 1992, Cellular immunology.

[24]  G. Nolan,et al.  Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. , 1992, Genes & development.

[25]  R. Roeder,et al.  Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. , 1992, Genes & development.

[26]  S. Mathur,et al.  Epstein Barr virus/complement C3d receptor is an interferon alpha receptor. , 1991, The EMBO journal.

[27]  M. Kazatchkine,et al.  Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. , 1991, Journal of immunology.

[28]  S. Poppema,et al.  Human marginal zone b cells are not an activated b cell subset: strong expression of cd21 as a putative mediator for rapid b cell activation , 1989, European journal of immunology.

[29]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[30]  John D Lambris,et al.  Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies , 1988, European journal of immunology.

[31]  D. Fearon,et al.  Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1 , 1988, The Journal of experimental medicine.

[32]  E. Kieff,et al.  Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis , 1987, Cell.

[33]  L. Young,et al.  EPSTEIN-BARR VIRUS RECEPTORS ON HUMAN PHARYNGEAL EPITHELIA , 1986, The Lancet.

[34]  A. Freedman,et al.  Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. , 1985, Journal of immunology.

[35]  M. Cooper,et al.  Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. , 1984, Journal of immunology.

[36]  P. A. Biro,et al.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Fearon,et al.  Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. , 2000, Annual review of immunology.

[38]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[39]  S. Akira,et al.  NF-IL6 and NF-κB in Cytokine Gene Regulation**This article was accepted for publication on 27 September 1996. , 1997 .

[40]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[41]  L. G. Davis,et al.  DEAE Dextran–Mediated Transfection of Nonadherent and Adherent Mammalian Cells , 1986 .